Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients

Oncology Letters

Volumn 9, Issue 2, 2015, Pages 955-963

  Ding, Chaofeng ^a,b   Yang, Zhe ^a   Lv, Zhen ^b   Du, Chengli ^b   Xiao, Heng ^b   Peng, Chuanhui ^a   Cheng, Shaobing ^b   Xie, Haiyang ^a,b   Zhou, Lin ^a,b   Wu, Jian ^a,b   Zheng, Shusen ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma; Long non coding RNA; Progression; PVT1; Recurrence

Indexed keywords

ALPHA FETOPROTEIN; LONG UNTRANSLATED RNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE; ONCOGENE PVT1; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; VERY ELDERLY;

EID: 84918798201     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2730     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
3. Cha C, Fong Y, Jarnagin WR, Blumgart LH and DeMatteo RP: Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197: 753-758, 2003.
4. Shah SA, Cleary SP, Wei AC, et al: Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 141: 330-339, 2007.
5. Zimmerman MA, Ghobrial RM, Tong MJ, et al: Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg 143: 182-188; discussion 188, 2008.
6. Wilusz JE, Sunwoo H and Spector DL: Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23: 1494-1504, 2009.
7. Mercer TR, Dinger ME and Mattick JS: Long non-coding RNAs: insights into functions. Nat Rev Genet 10: 155-159, 2009.
8. Tsai MC, Spitale RC and Chang HY: Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 71: 3-7, 2011.
9. Wang KC and Chang HY: Molecular mechanisms of long noncoding RNAs. Mol Cell 43: 904-914, 2011.
10. Yang Z, Zhou L, Wu LM, et al: Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 18: 1243-1250, 2011.
11. Ishibashi M, Kogo R, Shibata K, et al: Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep 29: 946-950, 2013.
12. Lai MC, Yang Z, Zhou L, et al: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29: 1810-1816, 2012.
13. Braconi C, Kogure T, Valeri N, et al: microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30: 4750-4756, 2011.
14. Zhang L, Yang F, Yuan JH, et al: Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 34: 577-586, 2013.
15. Takahashi Y, Sawada G, Kurashige J, et al: Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 110: 164-171, 2014.
16. Guan Y, Kuo WL, Stilwell JL, et al: Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13: 5745-5755, 2007.
17. Schlaeger C, Longerich T, Schiller C, et al: Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 47: 511-520, 2008.
18. Ding J, Huang S, Wu S, et al: Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 12: 390-399, 2010.
19. Edmondson HA and Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7: 462-503, 1954.
20. Greene FL, Page DL, Fleming ID, et al (eds): Liver. In: AJCC Cancer Staging Manual. 6th edition. Springer, Chicago, IL, p435, 2002.
21. Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699, 1996.
22. Yao FY, Ferrell L, Bass NM, et al: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394-1403, 2001.
23. Zheng SS, Xu X, Wu J, et al: Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 85: 1726-1732, 2008.
24. Gibb EA, Vucic EA, Enfield KS, et al: Human cancer long non-coding RNA transcriptomes. PLoS One 6: e25915, 2011.
25. Prensner JR, Iyer MK, Balbin OA, et al: Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 29: 742-749, 2011.
26. Gutschner T and Diederichs S: The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9: 703-719, 2012.
27. Guttman M and Rinn JL: Modular regulatory principles of large non-coding RNAs. Nature 482: 339-346, 2012.
28. Rinn JL, Kertesz M, Wang JK, et al: Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323, 2007.
29. Tripathi V, Ellis JD, Shen Z, et al: The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39: 925-938, 2010.
30. Barsotti AM, Beckerman R, Laptenko O, et al: p53-dependent induction of PVT1 and miR-1204. J Biol Chem 287: 2509-2519, 2012.